|
|
Volumn 122, Issue 23, 2013, Pages 3843-3844
|
|
Ruxolitinib is a potent immunosuppressive compound: is it time for anti-infective prophylaxis?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIINFECTIVE AGENT;
ANTIVIRUS AGENT;
IMMUNOSUPPRESSIVE AGENT;
JANUS KINASE;
PROTEIN KINASE INHIBITOR;
PYRAZOLE DERIVATIVE;
RUXOLITINIB;
ANTAGONISTS AND INHIBITORS;
HUMAN;
IMMUNOLOGY;
INFECTION CONTROL;
PRIMARY MYELOFIBROSIS;
PROCEDURES;
RISK FACTOR;
ANTI-BACTERIAL AGENTS;
ANTIVIRAL AGENTS;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
INFECTION CONTROL;
JANUS KINASES;
PRIMARY MYELOFIBROSIS;
PROTEIN KINASE INHIBITORS;
PYRAZOLES;
RISK FACTORS;
|
|
EID: 84892882122
PISSN: None
EISSN: 15280020
Source Type: Journal
DOI: 10.1182/blood-2013-10-531103 Document Type: Letter |
|
Times cited : (138)
|
|
References (0)
|
